世界のバンコマイシン市場予測（～2028年）：ダプトマイシン、リネゾリド、キヌプリスチン、アンピシリン、クロラムフェニコール、その他

• 英文タイトル：Global Vancomycin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8983 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

バンコマイシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のバンコマイシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 バンコマイシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ダプトマイシン、リネゾリド、キヌプリスチン、アンピシリン、クロラムフェニコール、その他 用途別セグメントは次のように区分されます。 ・敗血症、肺感染症、皮膚軟部組織感染症、大腸炎＆腸炎症、感染症予防 世界のバンコマイシン市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer、Eli Lilly and Company、CJ CheilJedang、Xellia Pharmaceuticals ApS、VIANEX、Alchemia Limited、Alvogen、Aphios Corporation、Cellceutix Corporation、Enanta Pharmaceuticals、Helix BioMedix、LegoChem Biosciences、Lytix Biopharma、MGB Biopharma Limited、Microbiotix.、MicuRx Pharmaceuticals、Nabriva Therapeutics、NovaBay Pharmaceuticals、NovoBiotic Pharmaceuticals、Oragenics、Sealife Pharma、Taiwan Zhengde Pharmaceutical、Zhejiang Pharmaceutical、Zhejiang Haizheng Pharmaceutical、North China Pharmaceutical、Shenwei Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、バンコマイシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なバンコマイシンメーカーの企業概要、2019年～2022年までのバンコマイシンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なバンコマイシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別バンコマイシンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのバンコマイシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバンコマイシン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびバンコマイシンの産業チェーンを掲載しています。 ・第13、14、15章では、バンコマイシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Eli Lilly and Company、CJ CheilJedang、Xellia Pharmaceuticals ApS、VIANEX、Alchemia Limited、Alvogen、Aphios Corporation、Cellceutix Corporation、Enanta Pharmaceuticals、Helix BioMedix、LegoChem Biosciences、Lytix Biopharma、MGB Biopharma Limited、Microbiotix.、MicuRx Pharmaceuticals、Nabriva Therapeutics、NovaBay Pharmaceuticals、NovoBiotic Pharmaceuticals、Oragenics、Sealife Pharma、Taiwan Zhengde Pharmaceutical、Zhejiang Pharmaceutical、Zhejiang Haizheng Pharmaceutical、North China Pharmaceutical、Shenwei Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：ダプトマイシン、リネゾリド、キヌプリスチン、アンピシリン、クロラムフェニコール、その他 ・用途別分析2017年-2028年：敗血症、肺感染症、皮膚軟部組織感染症、大腸炎＆腸炎症、感染症予防 ・バンコマイシンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・バンコマイシンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・バンコマイシンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バンコマイシンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・バンコマイシンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Vancomycin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Vancomycin market size is estimated to be worth US$ 343.6 million in 2021 and is forecast to a readjusted size of USD 479.1 million by 2028 with a CAGR of 4.9% during review period. Sepsis accounting for % of the Vancomycin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Daptomycin segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Vancomycin include Pfizer, Eli Lilly and Company, CJ CheilJedang, Xellia Pharmaceuticals ApS, and VIANEX, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Vancomycin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Daptomycin
Linezolid
Quinupristin
Ampicillin
Chloramphenicol
Others
Market segment by Application can be divided into
Sepsis
Lung Infection
Skin Soft Tissue Infection
Colitis & Intestinal Inflammation
To Prevent Infection
The key market players for global Vancomycin market are listed below:
Pfizer
Eli Lilly and Company
CJ CheilJedang
Xellia Pharmaceuticals ApS
VIANEX
Alchemia Limited
Alvogen
Aphios Corporation
Cellceutix Corporation
Enanta Pharmaceuticals
Helix BioMedix
LegoChem Biosciences
Lytix Biopharma
MGB Biopharma Limited
Microbiotix.
MicuRx Pharmaceuticals
Nabriva Therapeutics
NovaBay Pharmaceuticals
NovoBiotic Pharmaceuticals
Oragenics
Sealife Pharma
Taiwan Zhengde Pharmaceutical
Zhejiang Pharmaceutical
Zhejiang Haizheng Pharmaceutical
North China Pharmaceutical
Shenwei Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vancomycin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vancomycin, with price, sales, revenue and global market share of Vancomycin from 2019 to 2022.
Chapter 3, the Vancomycin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vancomycin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Vancomycin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vancomycin.
Chapter 13, 14, and 15, to describe Vancomycin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Vancomycin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vancomycin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Daptomycin
1.2.3 Linezolid
1.2.4 Quinupristin
1.2.5 Ampicillin
1.2.6 Chloramphenicol
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vancomycin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Sepsis
1.3.3 Lung Infection
1.3.4 Skin Soft Tissue Infection
1.3.5 Colitis & Intestinal Inflammation
1.3.6 To Prevent Infection
1.4 Global Vancomycin Market Size & Forecast
1.4.1 Global Vancomycin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Vancomycin Sales in Volume (2017-2028)
1.4.3 Global Vancomycin Price (2017-2028)
1.5 Global Vancomycin Production Capacity Analysis
1.5.1 Global Vancomycin Total Production Capacity (2017-2028)
1.5.2 Global Vancomycin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vancomycin Market Drivers
1.6.2 Vancomycin Market Restraints
1.6.3 Vancomycin Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Vancomycin Product and Services
2.1.4 Pfizer Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Vancomycin Product and Services
2.2.4 Eli Lilly and Company Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CJ CheilJedang
2.3.1 CJ CheilJedang Details
2.3.2 CJ CheilJedang Major Business
2.3.3 CJ CheilJedang Vancomycin Product and Services
2.3.4 CJ CheilJedang Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Xellia Pharmaceuticals ApS
2.4.1 Xellia Pharmaceuticals ApS Details
2.4.2 Xellia Pharmaceuticals ApS Major Business
2.4.3 Xellia Pharmaceuticals ApS Vancomycin Product and Services
2.4.4 Xellia Pharmaceuticals ApS Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 VIANEX
2.5.1 VIANEX Details
2.5.2 VIANEX Major Business
2.5.3 VIANEX Vancomycin Product and Services
2.5.4 VIANEX Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Alchemia Limited
2.6.1 Alchemia Limited Details
2.6.2 Alchemia Limited Major Business
2.6.3 Alchemia Limited Vancomycin Product and Services
2.6.4 Alchemia Limited Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Alvogen
2.7.1 Alvogen Details
2.7.2 Alvogen Major Business
2.7.3 Alvogen Vancomycin Product and Services
2.7.4 Alvogen Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Aphios Corporation
2.8.1 Aphios Corporation Details
2.8.2 Aphios Corporation Major Business
2.8.3 Aphios Corporation Vancomycin Product and Services
2.8.4 Aphios Corporation Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cellceutix Corporation
2.9.1 Cellceutix Corporation Details
2.9.2 Cellceutix Corporation Major Business
2.9.3 Cellceutix Corporation Vancomycin Product and Services
2.9.4 Cellceutix Corporation Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Enanta Pharmaceuticals
2.10.1 Enanta Pharmaceuticals Details
2.10.2 Enanta Pharmaceuticals Major Business
2.10.3 Enanta Pharmaceuticals Vancomycin Product and Services
2.10.4 Enanta Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Helix BioMedix
2.11.1 Helix BioMedix Details
2.11.2 Helix BioMedix Major Business
2.11.3 Helix BioMedix Vancomycin Product and Services
2.11.4 Helix BioMedix Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 LegoChem Biosciences
2.12.1 LegoChem Biosciences Details
2.12.2 LegoChem Biosciences Major Business
2.12.3 LegoChem Biosciences Vancomycin Product and Services
2.12.4 LegoChem Biosciences Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Lytix Biopharma
2.13.1 Lytix Biopharma Details
2.13.2 Lytix Biopharma Major Business
2.13.3 Lytix Biopharma Vancomycin Product and Services
2.13.4 Lytix Biopharma Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 MGB Biopharma Limited
2.14.1 MGB Biopharma Limited Details
2.14.2 MGB Biopharma Limited Major Business
2.14.3 MGB Biopharma Limited Vancomycin Product and Services
2.14.4 MGB Biopharma Limited Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Microbiotix.
2.15.1 Microbiotix. Details
2.15.2 Microbiotix. Major Business
2.15.3 Microbiotix. Vancomycin Product and Services
2.15.4 Microbiotix. Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 MicuRx Pharmaceuticals
2.16.1 MicuRx Pharmaceuticals Details
2.16.2 MicuRx Pharmaceuticals Major Business
2.16.3 MicuRx Pharmaceuticals Vancomycin Product and Services
2.16.4 MicuRx Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Nabriva Therapeutics
2.17.1 Nabriva Therapeutics Details
2.17.2 Nabriva Therapeutics Major Business
2.17.3 Nabriva Therapeutics Vancomycin Product and Services
2.17.4 Nabriva Therapeutics Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 NovaBay Pharmaceuticals
2.18.1 NovaBay Pharmaceuticals Details
2.18.2 NovaBay Pharmaceuticals Major Business
2.18.3 NovaBay Pharmaceuticals Vancomycin Product and Services
2.18.4 NovaBay Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 NovoBiotic Pharmaceuticals
2.19.1 NovoBiotic Pharmaceuticals Details
2.19.2 NovoBiotic Pharmaceuticals Major Business
2.19.3 NovoBiotic Pharmaceuticals Vancomycin Product and Services
2.19.4 NovoBiotic Pharmaceuticals Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Oragenics
2.20.1 Oragenics Details
2.20.2 Oragenics Major Business
2.20.3 Oragenics Vancomycin Product and Services
2.20.4 Oragenics Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21 Sealife Pharma
2.21.1 Sealife Pharma Details
2.21.2 Sealife Pharma Major Business
2.21.3 Sealife Pharma Vancomycin Product and Services
2.21.4 Sealife Pharma Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22 Taiwan Zhengde Pharmaceutical
2.22.1 Taiwan Zhengde Pharmaceutical Details
2.22.2 Taiwan Zhengde Pharmaceutical Major Business
2.22.3 Taiwan Zhengde Pharmaceutical Vancomycin Product and Services
2.22.4 Taiwan Zhengde Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23 Zhejiang Pharmaceutical
2.23.1 Zhejiang Pharmaceutical Details
2.23.2 Zhejiang Pharmaceutical Major Business
2.23.3 Zhejiang Pharmaceutical Vancomycin Product and Services
2.23.4 Zhejiang Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.24 Zhejiang Haizheng Pharmaceutical
2.24.1 Zhejiang Haizheng Pharmaceutical Details
2.24.2 Zhejiang Haizheng Pharmaceutical Major Business
2.24.3 Zhejiang Haizheng Pharmaceutical Vancomycin Product and Services
2.24.4 Zhejiang Haizheng Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.25 North China Pharmaceutical
2.25.1 North China Pharmaceutical Details
2.25.2 North China Pharmaceutical Major Business
2.25.3 North China Pharmaceutical Vancomycin Product and Services
2.25.4 North China Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.26 Shenwei Pharmaceutical
2.26.1 Shenwei Pharmaceutical Details
2.26.2 Shenwei Pharmaceutical Major Business
2.26.3 Shenwei Pharmaceutical Vancomycin Product and Services
2.26.4 Shenwei Pharmaceutical Vancomycin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Vancomycin Breakdown Data by Manufacturer
3.1 Global Vancomycin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Vancomycin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Vancomycin
3.4 Market Concentration Rate
3.4.1 Top 3 Vancomycin Manufacturer Market Share in 2021
3.4.2 Top 6 Vancomycin Manufacturer Market Share in 2021
3.5 Global Vancomycin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Vancomycin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vancomycin Market Size by Region
4.1.1 Global Vancomycin Sales in Volume by Region (2017-2028)
4.1.2 Global Vancomycin Revenue by Region (2017-2028)
4.2 North America Vancomycin Revenue (2017-2028)
4.3 Europe Vancomycin Revenue (2017-2028)
4.4 Asia-Pacific Vancomycin Revenue (2017-2028)
4.5 South America Vancomycin Revenue (2017-2028)
4.6 Middle East and Africa Vancomycin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Vancomycin Sales in Volume by Type (2017-2028)
5.2 Global Vancomycin Revenue by Type (2017-2028)
5.3 Global Vancomycin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Vancomycin Sales in Volume by Application (2017-2028)
6.2 Global Vancomycin Revenue by Application (2017-2028)
6.3 Global Vancomycin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Vancomycin Sales by Type (2017-2028)
7.2 North America Vancomycin Sales by Application (2017-2028)
7.3 North America Vancomycin Market Size by Country
7.3.1 North America Vancomycin Sales in Volume by Country (2017-2028)
7.3.2 North America Vancomycin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Vancomycin Sales by Type (2017-2028)
8.2 Europe Vancomycin Sales by Application (2017-2028)
8.3 Europe Vancomycin Market Size by Country
8.3.1 Europe Vancomycin Sales in Volume by Country (2017-2028)
8.3.2 Europe Vancomycin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Vancomycin Sales by Type (2017-2028)
9.2 Asia-Pacific Vancomycin Sales by Application (2017-2028)
9.3 Asia-Pacific Vancomycin Market Size by Region
9.3.1 Asia-Pacific Vancomycin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Vancomycin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Vancomycin Sales by Type (2017-2028)
10.2 South America Vancomycin Sales by Application (2017-2028)
10.3 South America Vancomycin Market Size by Country
10.3.1 South America Vancomycin Sales in Volume by Country (2017-2028)
10.3.2 South America Vancomycin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vancomycin Sales by Type (2017-2028)
11.2 Middle East & Africa Vancomycin Sales by Application (2017-2028)
11.3 Middle East & Africa Vancomycin Market Size by Country
11.3.1 Middle East & Africa Vancomycin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Vancomycin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Vancomycin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Vancomycin
12.3 Vancomycin Production Process
12.4 Vancomycin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Vancomycin Typical Distributors
13.3 Vancomycin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---